Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
BMC Cancer|August 27, 2025
Bulgarian exploratory analysis of time from diagnosis to treatment of lung cancer patients (Beat) - a retrospective database study on the patient pathway and time from diagnosis to treatmentAssen Dudov, Nikolay Conev, Mila Petrova, et al.
BMC Palliative Care|April 2, 2021
Comparison of the health-related quality of life of end stage kidney disease patients on hemodialysis and non-hemodialysis management in UgandaPeace Bagasha, Elizabeth Namukwaya, Mhoira Leng, et al.
Frontiers in Public Health|May 30, 2023
A synthesis of concepts of resilience to inform operationalization of health systems resilience in recovery from disruptive public health events including COVID-19Geraldine McDarby, Redda Seifeldin, Yu Zhang, et al.
Plos Medicine|March 4, 2020
Illness-related suffering and need for palliative care in Rohingya refugees and caregivers in Bangladesh: A cross-sectional studyMegan Doherty, Liam Power, Mila Petrova, et al.
Research Synthesis Methods|September 28, 2020
Lost in reviews: Looking for the involvement of stakeholders, patients, public and other non-researcher contributors in realist reviewsRuth Abrams, Sophie Park, Geoff Wong, et al.
Frontiers in Oncology|April 17, 2026
Metachronous bilateral renal cancer with immune checkpoint blockade-mediated eradication of bone metastasis: case reportDimitar Metodiev, Tsvetan Borisov, Pierre-Alexis Da Costa, et al.
Contemporary Oncology (Poznan, Poland)|February 26, 2024
Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic diseaseKiril Zhelev, Maria Mihaylova-Hristov, Nikolay Conev, et al.
Cancers|July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter StudyNicolas Williet, Angelica Petrillo, Gaël Roth, et al.
The Oncologist|July 7, 2025
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancerLorenzo Antonuzzo, Hidenori Takahashi, Joon Oh Park, et al.
Cancers|April 14, 2026
Real-World Evidence of Atezolizumab Efficacy as Part of First-Line Treatment for Extensive-Stage SCLC in BulgariaManoela Manova, Boryana Ivanova, Rositsa Krasteva, et al.
Pageof 4